Variant report

Variant	rs7596380
Chromosome Location	chr2:230994057-230994058
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 42 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:35)

rs_ID	r²[population]
rs11893862	0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs12052677	0.96[ASN][1000 genomes]
rs12052680	0.89[AMR][1000 genomes];0.91[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs12616682	0.88[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs16826639	0.87[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs16826643	0.84[AFR][1000 genomes];0.83[AMR][1000 genomes]
rs34371224	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs35376505	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs35490805	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs35959887	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs4263101	0.81[EUR][1000 genomes]
rs4277512	0.96[ASN][1000 genomes]
rs4972934	0.80[EUR][1000 genomes]
rs4972935	0.80[EUR][1000 genomes]
rs4973265	0.82[EUR][1000 genomes]
rs55982019	0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs58937409	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs59556384	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs62190338	0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs62190342	0.88[AFR][1000 genomes];0.85[AMR][1000 genomes]
rs62190343	0.92[AFR][1000 genomes];0.85[AMR][1000 genomes]
rs62190344	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs62190347	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs62190348	0.88[AFR][1000 genomes];0.84[AMR][1000 genomes]
rs6414216	0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6436899	0.80[EUR][1000 genomes]
rs66869073	0.88[AFR][1000 genomes];0.85[AMR][1000 genomes]
rs6705913	0.91[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs6714834	0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6715401	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6743476	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6743904	0.96[ASN][1000 genomes]
rs6758938	0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs6759053	0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs7558144	0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1007920	chr2:230775427-231065592	Enhancers Strong transcription Active TSS Flanking Active TSS Weak transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
2	nsv1001562	chr2:230862717-231187043	Flanking Active TSS ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Active TSS Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
3	nsv536156	chr2:230862717-231187043	Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Weak transcription Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
4	nsv498047	chr2:230951712-231250489	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS ZNF genes & repeats Strong transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
5	nsv875942	chr2:230959532-231008980	Enhancers Weak transcription Active TSS Flanking Active TSS ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
6	nsv875943	chr2:230960946-231027162	Weak transcription Enhancers Active TSS Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
7	esv2830298	chr2:230988148-230995447	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:38 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:230990800-230994200	Enhancers	Monocytes-CD14+_RO01746	blood
2	chr2:230991600-230995800	Weak transcription	Lung	lung
3	chr2:230992000-230995800	Weak transcription	Fetal Muscle Leg	muscle
4	chr2:230992800-230999200	Weak transcription	Primary neutrophils fromperipheralblood	blood
5	chr2:230993000-230995600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr2:230993200-230994200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr2:230993400-230994200	Active TSS	Duodenum Smooth Muscle	Duodenum
8	chr2:230993400-230994400	Flanking Active TSS	Adipose Nuclei	Adipose
9	chr2:230993600-230994200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
10	chr2:230993600-230994200	Flanking Active TSS	Brain Anterior Caudate	brain
11	chr2:230993600-230994200	Flanking Active TSS	Brain Hippocampus Middle	brain
12	chr2:230993600-230994200	Flanking Active TSS	Fetal Lung	lung
13	chr2:230993600-230994200	Active TSS	Placenta	Placenta
14	chr2:230993600-230994200	Active TSS	Rectal Smooth Muscle	rectum
15	chr2:230993600-230994600	Enhancers	Rectal Mucosa Donor 31	rectum
16	chr2:230993800-230994200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr2:230993800-230994200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
18	chr2:230993800-230994200	Enhancers	Brain Angular Gyrus	brain
19	chr2:230993800-230994200	Enhancers	Brain Cingulate Gyrus	brain
20	chr2:230993800-230994200	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
21	chr2:230993800-230994200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
22	chr2:230993800-230994200	Flanking Active TSS	NHLF	lung
23	chr2:230993800-230994400	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr2:230993800-230994400	Flanking Active TSS	Duodenum Mucosa	Duodenum
25	chr2:230993800-230994400	Enhancers	Right Atrium	heart
26	chr2:230993800-230994400	Enhancers	Skeletal Muscle Female	skeletal muscle
27	chr2:230993800-230994400	Enhancers	Spleen	Spleen
28	chr2:230993800-230994600	Enhancers	Sigmoid Colon	Sigmoid Colon
29	chr2:230993800-230994600	Enhancers	Skeletal Muscle Male	skeletal muscle
30	chr2:230993800-230994600	Flanking Active TSS	NHDF-Ad	bronchial
31	chr2:230993800-230995400	Enhancers	HepG2	liver
32	chr2:230993800-230997000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
33	chr2:230994000-230994200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr2:230994000-230994200	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
35	chr2:230994000-230994200	Enhancers	Brain Substantia Nigra	brain
36	chr2:230994000-230995400	Weak transcription	Ovary	ovary
37	chr2:230994000-230995400	Weak transcription	Osteobl	bone
38	chr2:230994000-230998800	Weak transcription	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links